1Xu F,Huang JB,Jiang L,et al. Amelioration of cyclosporine nephrotoxi city by Cordyceps sinensis in kidney- transplanted recipients[J].Nephro Dial Transplant, 1995,10 ( 1 ): 144 - 145.
2Xu F,Wu ZH,Zhang ZY,et al. Concentration - dependent effect of cy closporine on plasma lipid in renal transplant recipients[ J ] . Clin Nephrol, 1998,50( 1 ) :67 - 68.
3Chisholm MA,Mulloy LL,Jagadeesan M,et al. Impact of clinical phar macy services on renal transplant patients compliance with immunosuppressive medications [ J ]. Clin Transplant, 2001,15 (5): 330 - 336.
4Xu F, Chen ZL, Jin WJ,et al. Ideal therapeutic range of cyclosporine in whole blood in kidney-transplanted recipients[J]. Int J Clin Phar macol Res, 1993, 13(3) :221 -224.
6Mueller EA,Kovarik JM,Van Bree JB,et al. Pharmacokinetics and tol erability of a microemulsion formation of cyclosporine in renal allograft recipients[J]. Transplantation, 1994,57 (6) :1 178 - 1 179.
7Keown P, Landsberg D, Halloram P, et al. A randomized, prospective multicenter pharmacoepidemiologic study of cyclosporine microemulsion in stable renal graft recipients [ J ]. Transplantation, 1996,62 (9): 1 744 - 1752.
8DeFronzo RA. Pharmacologic therapy for type 2 diabetes mellitus[J]. Ann Intern Med,1999,131(4):281.
9Botelho RJ, Dudrak R 2nd. Home assessment of adherence to long-term medication in the elderly[J]. J Fam Pract, 1992,35(1):61.
10Eisen SA, Miller DK, Woodward RS, et al. The effect of prescribed daily dose frequency on patient medication compliance[J]. Arch Intern Med, 1990,150(9):1881.
